Naiyer A. Rizvi, MD

I am a medical oncologist specializing in the treatment of people with lung cancer.

I believe we are in the midst of a revolution in terms of drug development and personalized medicine. This research landscape changes rapidly and our role is to remain on the forefront of oncology research by developing more effective treatments.

I have been taking care of patients with cancer since joining Memorial-Sloan Kettering in 2002. As part of this responsibility I have been devoted to searching for new medicines that directly target tumors, as well as to developing immunotherapy approaches to harness the immune system to fight against cancer.

more…

I have been a member of the Developmental Therapeutics Group since its inception in 2010. This team of medical oncologists aims to provide access to the newest Phase 1 agents for patients with all types of cancer throughout the Memorial Sloan-Kettering system.

In addition to serving as a reviewer for the Journal of Clinical Oncology as well as Cancer Chemotherapy and Pharmacology, I have authored or co-authored numerous journal articles, reviews, and monographs on first in-human trials of new drugs and targeted therapies for non-small cell lung cancer.

Before Memorial Sloan-Kettering and my joint appointment at Weill Cornell Medical College, I was an attending physician at Lombardi Cancer Center at Georgetown University. My oncology training was conducted at Beth Israel Hospital/Harvard Medical School. I received my medical degree and completed my residency at the University of Manitoba in Winnipeg, Canada.

Location

New York City

Appointments for New Patients

866-675-5864 (866-MSK-LUNG)

Phone

646-888-4204

Clinical Expertise

Thoracic Oncology; Developmental Therapeutics

Languages Spoken

English

Education

MD, University of Manitoba

Residencies

University of Manitoba

Fellowships

Beth Israel Hospital/Harvard Medical School

Board Certifications

Internal Medicine; Medical Oncology

See My Colleagues in:

Department of Medicine›Thoracic Oncology Service

Clinical Trials Led by Naiyer A. Rizvi

A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma

A Phase I Study of Nivolumab with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer

A Phase Ib Study of Combination Therapy with MSC1936369B and SAR245409 in Patients with Locally Advanced or Metastatic Solid Tumors

A Phase II Study of MPDL3280A in Patients with PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Phase II Study of Nivolumab in Patients with Previously Treated Advanced Squamous Cell Lung Cancer

A Phase III Study of BMS-936558 versus Docetaxel in Patients with Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

A Phase III Study of BMS-936558 versus Docetaxel in Previously Treated Advanced Squamous Cell Lung Cancer

Clinical Trials Co-Investigated by Naiyer A. Rizvi

A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer

A Phase I Study of MEDI3617 in Patients with Advanced Solid Tumors

A Phase I Study of PU-H71 in Patients with Advanced Cancer

A Phase II Study of BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer

A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer

A Study of the Biologic Effects of BMS-936558 in Patients with Inoperable or Metastatic Melanoma

Publications by Naiyer A. Rizvi

Visit PubMed for full listing of Naiyer A. Rizvi journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

cancer (KAN-ser)

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.